|
Title |
The financial burden of HIV care, including
antiretroviral therapy, on patients in three sites
in Indonesia |
Author(s) |
Sigit Riyarto, Budi Hidayat,Benjamin Johns,Ari Probandari, Yodi Mahendradhata, Adi Utarini,et al - Personal Name
|
Subject |
Health Economy |
Publisher |
Oxford University Press |
Publishing Year |
2010 |
Specific Detail Info |
This paper assesses the extent of the financial burden due to out-of-pocket
payments for health care incurred by people living with HIV (PLHIV) and
the effect of this burden on their financial capacity. Data were collected in
a cross-sectional survey of 353 PLHIV from three cities in Indonesia
(Jakarta, Jogjakarta and Merauke). Respondents in Jakarta were sampled
from one hospital and one non-governmental organization working with PLHIV.
In Jogjakarta and Merauke, all HIV patients on antiretroviral therapy (ART) who
came to selected hospitals during the interview period were asked to participate
in the survey. The survey collected data on the frequency and extent of
payments for HIV-related care, with answers cross-checked against medical
records. Results show that PLHIV had different burdens of payments in the
different geographical areas. On average, respondents in Jogjakarta spent 68%,
and PLHIV on ART in Jakarta spent 96%, of monthly expenditure for HIV related
care, indicating a substantial financial burden for many ART patients.
These patients depended on several sources of finance to cover the costs of their
care, with donations from their immediate family being the most common
method, selling assets and payments from personal income being the second
most common method in Jakarta and Jogjakarta, respectively. Most PLHIV in
these two areas did not have insurance. In Merauke, there were little observed
out-of-pocket payments because the government covers medical costs via the
local budget and health insurance for the poor.
The results of this study confirm previous findings that providing subsidized
ART drugs alone does not ensure financial accessibility to HIV care. Thus, the
government of Indonesia at central and local levels should consider covering HIV
care additional to providing antiretroviral drugs free of charge. Social health
insurance should also be encouraged. |
File Attachment |
LOADING LIST... |
|
Back To Previous |
|